Sub-chronic Effects of 5-hydroxytryptophan on Mood and Emotional Processing in Healthy Volunteers

Not Applicable

Completed

• Conditions: Mood
• Interventions: Dietary Supplement: 5-Hydroxytryptophan; Dietary Supplement: Pharmaceutical grade silica

• Registration Number: NCT01514409
• Lead Sponsor: Northumbria University

Brief Summary

5-hydroxytryptophan (5-HTP) is a nutritional supplement sold in many health food stores, and is taken in order to raise levels of serotonin in the brain. Serotonin is a neurotransmitter that is involved in the regulation of mood.

Previous research has assessed the effects of raising serotonin levels using tryptophan (the precursor of 5-HTP) and serotonergic antidepressants on emotional processing in healthy volunteers. However, to date there has been no human trial investigating the effects of 5-HTP on emotional processing in healthy volunteers.

Thus, the current study aims to assess the effects of 5-HTP, on emotional processing and mood in healthy volunteers.

Detailed Description

The serotonin precursor 5-HTP is sold as a nutritional supplement and has been used to offset low mood for over 30 years due to its ability to raise levels of neural serotonin. However, evidence for the efficiency of 5-HTP is limited and the mechanism of action of 5-HTP in offsetting low mood has not been well-characterised.

The current study assessed the ability of 5-HTP to induce biases for positive emotional material in healthy volunteers, similar to those induced by serotonergic antidepressants and the nutritional supplement tryptophan. The effects of 5-HTP on subjective mood and depressive symptoms were also assessed.

Participants were randomised to receive either 150mg of 5-HTP or placebo daily for 14 days. Depressive symptoms and subjective mood were assessed pre- and post-intervention. Emotional processing was assessed on the 15th day using a battery of emotionally valenced cognitive tasks.

Study Timeline

• Study Start: 2011-05
• Primary Completion: 2011-08
• Study Completion: 2011-08
• Status Verified: 2012-01
• Study First Submitted: 2012-01-17
• Study First Submitted QC: 2012-01-20
• Last Update Submitted: 2012-01-20
• Study First Posted: 2012-01-23
• Last Update Posted: 2012-01-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

• Male/Female
• Healthy
• Aged 18-65
• Not taking any herbal or prescription medications (excluding contraceptive pill)
• Free from depressive illness or mood disorder for the last 6 months
• Free of physical illness

Exclusion Criteria

• Physically ill
• History of medical illness
• Current or previous (6 month) history of psychiatric disorder
• Pregnant/breastfeeding
• Allergy or hypersensitivity to any of the ingredients contained in the investigational product
• Taking any medication (excluding contraceptive pill)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
5-Hydroxytryptophan	5-Hydroxytryptophan	-
Placebo	Pharmaceutical grade silica	-

Primary Outcome Measures

Name	Time	Method
Beck Depression Inventory-II (BDI-II)	14 days	The BDI-II is a measure used to assess the severity of depressive symptoms. It is comprised of 21 items that are scored on a scale ranging from 0-3, with total scores ranging from 0-63. Scores of over 16 are indicative of depressive symptoms.
Profile of Mood States-Bipolar (POMS-BI)	14 days	The POMS-BI is a measure used to assess subjective mood. It comprises 72 adjectives which describe mood states. Participants indicate how well the adjectives describe how they feel on a four point scale ranging from 0-3. The POMS-BI measures the following six bipolar mood states: composed-anxious, elated-depressed, agreeable-hostile, clearheaded-confused, energetic-tired, and confident-unsure.
Emotional Perception: Facial Expression Recognition Task	14 days	Participants are shown faces displaying five different emotions - happiness, sadness, fear, anger, and disgust. Each facial expression has been morphed between 0% (neutral) to 100% in 25% increments. Four examples of each emotion at each intensity are displayed on a computer screen (84 stimuli presentations in total). Faces are displayed for 500ms aand then replaced with a blank screen. Participants have to indicate what facial expression has been displayed by clicking the corresponding button on-screen with the mouse. Accuracy, reaction times, and misclassifications are measured.
Emotional Categorisation and Memory	14 days	Participants are shown sixty personality characteristics consecutively (30 agreeable, 30 disagreeable)on a computer screen in random order for 500ms each. Participants are asked to judge whether the personality traits are 'likeable' or 'dislikeable'. Classifications and reaction times for correct choices are recorded. Participants are then asked to recall as many personality characteristics as they can in order to assess their incidental memory for positive versus negative material.
Emotional Attention: Attentional Probe Task	14 days	The attentional probe task based on MacLeod, Matthews and Tata's (1986) visual attention paradigm is used to assess participants attention towards positive versus negatively valenced words. Accuracy and reaction time is recorded.

Trial Locations

Locations (1)

Northumbria University; 🇬🇧 Newcastle Upon Tyne, United Kingdom